| Name | Title | Contact Details |
|---|
Abbey Delray South is part of Lifespace Communities, Inc., a not-for-profit, multistate system of senior living communities that currently serves more than 5,100 people. For more than 40 years, Lifespace has created beautiful spaces for seniors to thrive and celebrate life every day. With decades of success and financial stability under its belt, Lifespace has earned national respect and recognition and, even more importantly, the trust of thousands of team members, residents and their families.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
I-Trax, Inc. provides integrated workplace medical, pharmacy, wellness, fitness, and disease management services. The Company delivers these services at or near the clientÍs worksite by opening, staffing and managing health centers, pharmacies and
EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
Doe & Ingalls is a Medford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.